TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26073276

Group type: COMPARATOR
Intervention: Active ITD
Number of subjects: 8719

Group type: COMPARATOR
Intervention: Sham ITD
Number of subjects: 8719
Study: 23922399

Group type: EXPERIMENTAL
Intervention: Fatigue self-management (FSM)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 111
Study: 21034744

Group type: EXPERIMENTAL
Intervention: Telaprevir 750 mg every 8 hours with peginterferon alfa-2a and ribavirin
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Telaprevir 1125 mg every 12 hours with peginterferon alfa-2a and ribavirin
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Telaprevir with peginterferon alfa-2b and ribavirin
Number of subjects: 161

Group type: COMPARATOR
Intervention: Peginterferon alfa-2a with ribavirin
Number of subjects: 161

Group type: COMPARATOR
Intervention: Peginterferon alfa-2b with ribavirin
Number of subjects: 161
Study: 17490759

Group type: EXPERIMENTAL
Intervention: Distal protection during primary angioplasty (DP group)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (angioplasty alone)
Number of subjects: 116
Study: 16319977

Group type: EXPERIMENTAL
Intervention: inter-Simple Sequence Repeat (inter-SSR) PCR
Number of subjects: 18
Study: 12568736

Group type: EXPERIMENTAL
Intervention: Jia-Wey Shiau-Yau San (JWSYS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous combined hormone replacement therapy (Premelle)
Number of subjects: 0
Study: 10735980

Group type: EXPERIMENTAL
Intervention: 13C-enriched diet after muscle glycogen depletion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group with no muscle glycogen depletion
Number of subjects: 6
Study: 8725417

Group type: EXPERIMENTAL
Intervention: Midazolam at a target plasma concentration of 150 ng/mL
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Midazolam at a target plasma concentration of 300 ng/mL
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control of hypertension with sufentanil
Number of subjects: 20
Study: 1561909

Group type: EXPERIMENTAL
Intervention: Buspirone 30 mg/d
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 3898348

Group type: EXPERIMENTAL
Intervention: Ranitidine, 150 mg twice daily
Number of subjects: 149

Group type: COMPARATOR
Intervention: Anticholinergic (glycopyrrolate, 2 mg three times daily) and antacid (60 ml/day)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 149

Group type: COMPARATOR
Intervention: Anticholinergic/antacid
Number of subjects: 149
Study: 30539891

Group type: EXPERIMENTAL
Intervention: Directly observed iron-folic acid (IFA) supplementation
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (IFA tablets without direct supervision)
Number of subjects: 400
Study: 27810483

Group type: EXPERIMENTAL
Intervention: Black tea consumption (>40 cup-years)
Number of subjects: 2111

Group type: EXPERIMENTAL
Intervention: Black tea consumption (endometrioid histotype)
Number of subjects: 2111

Group type: COMPARATOR
Intervention: Coffee and caffeinated soft drinks consumption
Number of subjects: 2111

Group type: COMPARATOR
Intervention: Any tea consumption
Number of subjects: 2111

Group type: COMPARATOR
Intervention: Green tea consumption
Number of subjects: 2111
Study: 25009139

Group type: EXPERIMENTAL
Intervention: Social Stories intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard stories (control)
Number of subjects: 50
Study: 22538329

Group type: EXPERIMENTAL
Intervention: Spotty calcification
Number of subjects: 1347

Group type: COMPARATOR
Intervention: Intensive low-density lipoprotein cholesterol and blood pressure lowering therapy
Number of subjects: 1347
Study: 20399404

Group type: EXPERIMENTAL
Intervention: Mothers In Motion (P-MIM) intervention
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 129
Study: 18824641

Group type: EXPERIMENTAL
Intervention: Milrinone use
Number of subjects: 232

Group type: COMPARATOR
Intervention: Nonusers of Milrinone
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Lower preoperative ejection fraction
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Mitral valve surgery
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Right ventricular dysfunction
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Higher mean pulmonary artery pressure
Number of subjects: 232
Study: 17158415

Group type: EXPERIMENTAL
Intervention: 400,000 IU vitamin A in 2 divided doses
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 200,000 IU vitamin A as a single dose plus placebo
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 168

Group type: COMPARATOR
Intervention: Baseline serum retinol concentration
Number of subjects: 168

Group type: COMPARATOR
Intervention: Baseline MRDR value
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Post-treatment serum retinol concentrations
Number of subjects: 168
Study: 14634738

Group type: EXPERIMENTAL
Intervention: Navigated knee prosthesis implantation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Free-hand knee prosthesis implantation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both navigated and free-hand procedures
Number of subjects: 25
Study: 10884642

Group type: EXPERIMENTAL
Intervention: Controlled injection pressure system
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional atraumatic syringe injection technique
Number of subjects: 80
Study: 8730070

Group type: EXPERIMENTAL
Intervention: Comparison of frequency response functions at different signal levels (stepped sine and random noise)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Comparison of coherence function at different signal levels (using random noise)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Hilbert transform of the estimated frequency response function
Number of subjects: 1
Study: 1593854

Group type: EXPERIMENTAL
Intervention: Low protein diet (0.55 g/kg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: High protein diet (2 g/kg/day)
Number of subjects: 14
Study: 6140202

Group type: EXPERIMENTAL
Intervention: High-dose 6-methylprednisolone
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: 6-methylprednisolone combined with 3 g of sulfasalazine
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: 3 g of sulfasalazine alone
Number of subjects: 452

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Continuous administration of low doses of 6-methylprednisolone or the combination regimen
Number of subjects: 452
Study: 31868920

Group type: EXPERIMENTAL
Intervention: STOPPFrail-guided deprescribing plan
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study: 30880285

Group type: EXPERIMENTAL
Intervention: CRP-guided antibiotic treatment (CRP ≥50 mg·L‐1)
Number of subjects: 220

Group type: COMPARATOR
Intervention: GOLD strategy (patient reported symptoms)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: CRP-guided antibiotic treatment
Number of subjects: 220

Group type: COMPARATOR
Intervention: GOLD strategy
Number of subjects: 220
Study: 29059190

Group type: EXPERIMENTAL
Intervention: Annual mass drug administration (MDA) of praziquantel
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: MDA every 2 years
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: MDA every other year
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (no MDA schedule specified)
Number of subjects: 75
Study: 25806862

Group type: EXPERIMENTAL
Intervention: Calibrated serum creatinine measurements
Number of subjects: 5210

Group type: COMPARATOR
Intervention: Noncalibrated serum creatinine measurements
Number of subjects: 5210
Study: 24258312

Group type: EXPERIMENTAL
Intervention: LEDT (light-emitting diode phototherapy at 630 nm; total energy density, 20.4 J/cm2)
Number of subjects: 17

Group type: COMPARATOR
Intervention: PLACEBO (phototherapy aimed at the muscle but turned off)
Number of subjects: 17
Study: 22027847

Group type: EXPERIMENTAL
Intervention: Full range of motion (FULL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Partial range of motion (PART)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 40
Study: 19443659

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Denileukin diftitox (denileukin)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Pentostatin
Number of subjects: 180
Study: 17299107

Group type: COMPARATOR
Intervention: Beverage containing green tea catechins, caffeine, and calcium (3 x 250-mL servings for 3 days)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 31
Study: 16845754

Group type: EXPERIMENTAL
Intervention: Exercise program (15 weeks, 31 hours total)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 40
Study: 11243304

Group type: EXPERIMENTAL
Intervention: Plasma leptin levels (mean, 11.1 ng/mL for boys and 19.7 ng/mL for girls in the highest quintile)
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: BMI and plasma leptin levels
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: Plasma leptin levels
Number of subjects: 1265
Study: 9621711

Group type: EXPERIMENTAL
Intervention: Progressive relaxation training (10 sessions over 2 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study: 8153985

Group type: EXPERIMENTAL
Intervention: Albendazole 600 mg single dose
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Albendazole 800 mg single dose
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg daily for 3 days
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg daily for 5 days
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Albendazole (all dosages)
Number of subjects: 245
Study: 2896600

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (1.5 mg/kg/day for one year)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31030594

Group type: EXPERIMENTAL
Intervention: Combination therapy (terbinafine 250 mg + itraconazole 200 mg)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg
Number of subjects: 3
Study: 29737494

Group type: EXPERIMENTAL
Intervention: Weight loss during low-calorie diet (11.3% weight loss)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Addition of 500 mg (1, 3)(1, 6)-β-glucan (BG) daily
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group of 20 normal-weight subjects
Number of subjects: 52
Study: 28430976

Group type: COMPARATOR
Intervention: Reboxetine (8 mg single dose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Reboxetine (8 mg/day for 21 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 26182774

Group type: EXPERIMENTAL
Intervention: Local steroid injection
Number of subjects: 116

Group type: COMPARATOR
Intervention: Mini incision technique
Number of subjects: 116
Study: 24129852

Group type: EXPERIMENTAL
Intervention: Stool transplantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antibiotic therapy
Number of subjects: 0
Study: 21435141

Group type: EXPERIMENTAL
Intervention: 10-mg dapagliflozin fed (high-fat meal)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 10-mg dapagliflozin fasted
Number of subjects: 14
Study: 19455069

Group type: EXPERIMENTAL
Intervention: 1-month cessation
Number of subjects: 1535

Group type: EXPERIMENTAL
Intervention: 2-month cessation
Number of subjects: 1535

Group type: COMPARATOR
Intervention: No cessation
Number of subjects: 1535

Group type: EXPERIMENTAL
Intervention: Estrogen-plus-progestin users
Number of subjects: 1535
Study: 16827738

Group type: EXPERIMENTAL
Intervention: Titanium abutment with cemented implant-supported single-tooth crown
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gold-alloy abutment with cemented implant-supported single-tooth crown
Number of subjects: 20
Study: 12723857

Group type: EXPERIMENTAL
Intervention: Occlusal splint therapy (S), nonsteroid anti-inflammatory with orphenadrine citrate (O), and benzodiazepine (B)
Number of subjects: 21
Study: 10786738

Group type: EXPERIMENTAL
Intervention: Fentanyl 100 microg i.v. (Group F)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bupivacaine 2.5 mg/ml for infiltration of trocar sites (Group B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg i.v. (Group T)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (Group P)
Number of subjects: 80
Study: 9453906

Group type: EXPERIMENTAL
Intervention: Laparoscopic transabdominal (TAPP) approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open approach (Shouldice) without mesh implantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic preperitoneal (TEP) approach
Number of subjects: 0
Study: 8440094

Group type: EXPERIMENTAL
Intervention: Lovastatin (up-titrated from 20 mg to 80 mg/day during the first 16 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3527514

Group type: EXPERIMENTAL
Intervention: Tripamide 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tripamide 25 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tripamide 50 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tripamide 100 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31325546

Group type: EXPERIMENTAL
Intervention: Rural hospice family caregivers
Number of subjects: 196

Group type: COMPARATOR
Intervention: Urban hospice family caregivers
Number of subjects: 196
Study: 29037786

Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation (GPR) session
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 64
Study: 25502581

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg orally daily for 12 months)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Losartan (in vitro treatment)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Amlodipine (10 mg orally daily for 12 months)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Amlodipine (in vitro treatment)
Number of subjects: 130
Study: 23967636

Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Medication group
Number of subjects: 200
Study: 21215439

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH)
Number of subjects: 279
Study: 18268422

Group type: EXPERIMENTAL
Intervention: Oxygen therapy applied by nasal prongs
Number of subjects: 18

Group type: COMPARATOR
Intervention: Air delivered by nasal prongs
Number of subjects: 18
Study: 16809237

Group type: EXPERIMENTAL
Intervention: CREON2000 units
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo units
Number of subjects: 19
Study: 14666022

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control
Number of subjects: 85
Study: 10695905

Group type: EXPERIMENTAL
Intervention: Opioid bolus regimen (7.5 microg x kg(‐1) fentanyl, 70% N2O, with 2.5 microg x kg(‐1) supplements as needed)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Opioid infusion (Alfentanil 50 microg x kg(‐1) bolus, 1‐1.5 microg x kg(‐1) x min(‐1) infusion, 70% N2O)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Isoflurane 0.3% (Fentanyl 1 microg x kg(‐1), 70% N2O, isoflurane 0.3% expired)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Isoflurane 0.7% (Fentanyl 1 microg x kg(‐1), 70% N2O, isoflurane 0.7% expired)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nitrous oxide with bolus supplementation
Number of subjects: 180
Study: 9082104

Group type: EXPERIMENTAL
Intervention: Topical cefazolin (group 2)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Intravenous cefazolin (group 1)
Number of subjects: 189
Study: 1417231

Group type: EXPERIMENTAL
Intervention: Capiox (membrane oxygenator)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Polystan (bubbler)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: William Harvey (bubbler)
Number of subjects: 51
Study: 6362715

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 80
Study: 30857952

Group type: EXPERIMENTAL
Intervention: Cemented total knee arthroplasty
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cementless total knee arthroplasty
Number of subjects: 85
Study: 30429144

Group type: EXPERIMENTAL
Intervention: Zero-balance goal-directed fluid therapy (GDT)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 310
Study: 26272051

Group type: COMPARATOR
Intervention: Dutasteride (low-dose 0.5 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Dutasteride (high-dose 2.5 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 24645970

Group type: EXPERIMENTAL
Intervention: Group A: 20 mJ, density 10%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group A: 20 mJ, density 20%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group B: 10 mJ, density 10%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group B: 20 mJ, density 10%
Number of subjects: 20
Study: 22494776

Group type: EXPERIMENTAL
Intervention: Specific movement control exercises (SMCE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General exercises
Number of subjects: 0
Study: 19490746

Group type: EXPERIMENTAL
Intervention: Psychosocial family intervention, individual counselling and standard treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Individual counselling and standard treatment
Number of subjects: 50
Study: 17295567

Group type: EXPERIMENTAL
Intervention: Fluoxetine (60 mg) plus group behavioral quit‐smoking treatment for 12 weeks
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo plus group behavioral quit‐smoking treatment for 12 weeks
Number of subjects: 247
Study: 15591164

Group type: EXPERIMENTAL
Intervention: R207910
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isoniazid and Rifampin
Number of subjects: 0
Study: 12501741

Group type: EXPERIMENTAL
Intervention: APN intervention
Number of subjects: 0
Study: 11350324

Group type: EXPERIMENTAL
Intervention: Bupivacaine field block administered after induction but before surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bupivacaine field block administered after surgery but before the end of anaesthesia
Number of subjects: 40
Study: 9646424

Group type: EXPERIMENTAL
Intervention: Varicocelectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 8159506

Group type: EXPERIMENTAL
Intervention: ESSR feeding method
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 3131041

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (NTG) at doses ranging from 10 to 120 micrograms/min (mean = 52 +/- 33 micrograms/min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (NTG)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sublingual NTG (0.4 mg) as a positive control
Number of subjects: 10
Study: 30261883

Group type: EXPERIMENTAL
Intervention: Standing desks in intervention schools (10 schools: 5 primary, 5 secondary) for 6 months.
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Focus groups and interviews with pupils and teachers regarding standing desks.
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Quantitative process evaluation data from intervention group.
Number of subjects: 311

Group type: COMPARATOR
Intervention: Control schools (9 schools: 5 primary, 4 secondary).
Number of subjects: 311
Study: 28363702

Group type: EXPERIMENTAL
Intervention: Communication skills training for physiotherapists (8 hours)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group with physiotherapist completing a 1-hour workshop on evidence-based chronic low back pain management
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Communication skills training for physiotherapists
Number of subjects: 255
Study: 25750876

Group type: EXPERIMENTAL
Intervention: Dual-task training (simultaneous balance and cognitive training using the BioRescue)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (conventional balance training)
Number of subjects: 20
Study: 24534303

Group type: EXPERIMENTAL
Intervention: Bilateral thoracic paravertebral block
Number of subjects: 40
Study: 21160312

Group type: EXPERIMENTAL
Intervention: Defunctioning stomas (n = 116)
Number of subjects: 234

Group type: COMPARATOR
Intervention: No defunctioning stomas (n = 118)
Number of subjects: 234
Study: 18240348

Group type: EXPERIMENTAL
Intervention: Triple therapy plus ecabet sodium (group B)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Standard triple therapy (group A)
Number of subjects: 257
Study: 16999353

Group type: EXPERIMENTAL
Intervention: Edgewise appliance combined with flat bite plate treatment
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 65
Study: 12742208

Group type: EXPERIMENTAL
Intervention: Open tension-free inguinal hernia repair
Number of subjects: 2165

Group type: COMPARATOR
Intervention: Laparoscopic tension-free inguinal hernia repair
Number of subjects: 2165
Study: 10816930

Group type: EXPERIMENTAL
Intervention: Referral guidelines for orthodontic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no referral guidelines)
Number of subjects: 0
Study: 8784319

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 20